Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: LEINCO TECHNOLOGIES, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2024-10-31 to 2024-12-30
Current total value of award: $33125
Description: MONOCLONAL ANTIBODIES FROM KNOCKOUT MICE WHO HAVE BEEN IN-VIVO GENETICALLY IMMUNIZED WITH INTERFERON-ALPHA/BETA RECEPTOR ALPHA CHAIN PROTEIN.